An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion
2022 · Nature Communications · 115 citations
https://doi.org/10.1038/s41467-022-28653-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
5.6K
Citations
26
h-index
30
i10-index
Dmitriy Lukashev is an academic researcher from Novartis (United States). The author has contributed to research in topics: Adenosine and Purinergic Signaling & Immune Cell Function and Interaction & Cancer, Hypoxia, and Metabolism. The author has an h-index of 26, co-authored 32 publications.
https://doi.org/10.1038/s41467-022-28653-6
https://doi.org/10.1593/neo.92106
https://doi.org/10.1002/ddr.10428
Click to start Chat